Are you working on these ATMP's or clearing a path to continuous biologics manufacturing? ISPE invites you to submit a proposal for our 2018 ISPE Biopharmaceutical Manufacturing Conference , December 10-12, Huntington Beach, CA
The 2018 ISPE Biopharmaceutical Manufacturing Conference focuses on the quickly evolving science of biologics manufacturing for new modalities, and the novel technologies that leverage existing capacity and move us towards continuous manufacturing. Share your expertise and help your peers prepare to manufacture these novel medicines and deliver on our promise of supplying life changing medicines to patients across the globe.
The call for proposals is open until May 30, 2018.
I speak for all the conference committee volunteers when I say we look forward to reading your proposals and learning how you are propelling the industry forward.
As with all aspects of our life sciences industry, understanding how we can best meet the needs of patients with the timely delivery of life saving and sustaining products is of paramount concern. During the years since the global pandemic, the expectations and pressures on the pharmaceutical industry with respect to development, speed to market, quality and sustainability have increased...
At the 2024 ISPE Europe Annual Conference, held in Lisbon, Portugal, 16-18 April, Richard L. Friedman, MS, Deputy Director of the US Food and Drug Administration’s (US FDA) Office of Manufacturing Quality, in...
Insight from Austria’s Regulatory Authority Representative
At the 2024 ISPE Aseptic Conference, held March 12-13 in Vienna, Austria, Christina Meissner, a European Union Good Manufacturing Practice (GMP) inspector at the Austrian Agency for Health and Food Safety since 2013, and Chair of the PIC/S Drafting Group on Annex 2A and 2B, published in May 2021, offered a presentation titled...